Memorial Sloan Kettering Cancer Center Sleepy Hollow: Clinical Trials at Sleepy Hollow

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan Kettering Cancer Center Sleepy Hollow below. You can also explore our complete listing of clinical trials available at Memorial Sloan Kettering.

Showing 1 - 20 of 93 trials
Title Investigatorsort icon Disease(s)
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
[Protocol 11-112]
Zaider, Talia
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
A Phase I/II Study of Ruxolitinib plus Erlotinib in Patients with Erlotinib-Resistant Lung Adenocarcinoma
[Protocol 14-043]
Yu, Helena
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of CO-1686 in Patients with Previously Treated Non-Small Cell Lung Cancer Containing an EGFR T790M Mutation
[Protocol 14-084]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase III Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Whole-Lung IMRT in Children and Adults with Synovial Sarcoma that Spread to the Lungs
[Protocol 14-075]
Wolden, Suzanne
  • Sarcomas
    • Soft Tissue Sarcoma
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023]
Van Zee, Kimberly
  • Breast Cancer
A Phase II Study of Exemestane with and without Enzalutamide in Women with Advanced Hormone Receptor-Positive Breast Cancer
[Protocol 13-257]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany
  • Breast Cancer
A Randomized Phase III Study of Standard Chemotherapy with and without Brentuximab in Patients Newly Diagnosed with Advanced Hodgkin Lymphoma
[Protocol 13-056]
Straus, David
  • Lymphoma
    • Hodgkin's Disease
A Phase II Study Comparing Romiplostim with Observation for Chemotherapy-Induced Thrombocytopenia
[Protocol 13-132]
Soff, Gerald
  • Hematology
    • Hematologic Disorders
  • Solid Tumors
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087]
Saltz, Leonard
  • Colorectal Cancer
    • Rectal Cancer
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of Docetaxel Alone or with OGX-427 in Patients with Recurrent or Refractory Urothelial Cancers
Relapsed/Refractory
[Protocol 13-127]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of MEDI4736 in Patients with Stage IIIB-IV Non-Small Cell Lung Cancer Containing the PD-L1 Protein
[Protocol 14-103]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 13-113]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase I/II Study of Crizotinib and Ganetespib (STA-9090) in ALK-Positive Lung Cancers
[Protocol 12-015]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma